Jane Street’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-52,920
| Closed | -$12.2K | – | 6934 |
|
|
2024
Q4 | $12.2K | Buy |
+52,920
| New | +$12.2K | ﹤0.01% | 5654 |
|
|
2024
Q3 | – | Sell |
-39,181
| Closed | -$202K | – | 6693 |
|
|
2024
Q2 | $202K | Sell |
39,181
-133,336
| -77% | -$688K | ﹤0.01% | 5385 |
|
|
2024
Q1 | $923K | Buy |
172,517
+151,382
| +716% | +$810K | ﹤0.01% | 3316 |
|
|
2023
Q4 | $165K | Buy |
+21,135
| New | +$165K | ﹤0.01% | 5098 |
|
|
2023
Q1 | – | Sell |
-16,319
| Closed | -$58.6K | – | 6356 |
|
|
2022
Q4 | $58.6K | Buy |
+16,319
| New | +$58.6K | ﹤0.01% | 4835 |
|
|
2022
Q3 | – | Sell |
-1,709
| Closed | -$16K | – | 6484 |
|
|
2022
Q2 | $16K | Buy |
1,709
+329
| +24% | +$3.08K | ﹤0.01% | 5164 |
|
|
2022
Q1 | $16K | Sell |
1,380
-1,280
| -48% | -$14.8K | ﹤0.01% | 5405 |
|
|
2021
Q4 | $87K | Sell |
2,660
-5,201
| -66% | -$170K | ﹤0.01% | 4715 |
|
|
2021
Q3 | $352K | Buy |
7,861
+2,557
| +48% | +$114K | ﹤0.01% | 3775 |
|
|
2021
Q2 | $289K | Buy |
5,304
+1,524
| +40% | +$83K | ﹤0.01% | 4026 |
|
|
2021
Q1 | $283K | Sell |
3,780
-1,723
| -31% | -$129K | ﹤0.01% | 3971 |
|
|
2020
Q4 | $597K | Buy |
+5,503
| New | +$597K | ﹤0.01% | 2588 |
|